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Abstract
Understanding how bones are innately designed, robustly developed and delicately maintained through intricate
anatomical features and physiological processes across the lifespan is vital to inform our assessment of normal bone
health, and essential to aid our interpretation of adverse clinical outcomes affecting bone through primary or secondary
causes. Accordingly this review serves to introduce new researchers and clinicians engaging with bone and mineral
metabolism, and provide a contemporary update for established researchers or clinicians. Specifically, we describe the
mechanical and non-mechanical functions of the skeleton; its multidimensional and hierarchical anatomy (macroscopic,
microscopic, organic, inorganic, woven and lamellar features); its cellular and hormonal physiology (deterministic and
homeostatic processes that govern and regulate bone); and processes of mechanotransduction, modelling, remodelling
and degradation that underpin bone adaptation or maladaptation. In addition, we also explore commonly used methods for
measuring bone metabolic activity or material features (imaging or biochemical markers) together with their limitations.
Keywords: Cortical, Imaging, Modelling, Remodelling, Trabecular

Introduction
Bone is a remarkable and exquisite biomaterial. It is
highly adaptive, structurally dynamic and metabolically
active, and is superior to all other biomaterials in terms
of strength and toughness1-4. In particular, bone structure,
size and strength are reliant upon and responsive to the
routine physiological and mechanical demands placed
upon it5-12. Mechanical stimuli thus initiate or inhibit bone
modelling and remodelling processes in response to
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variations in internal or external forces or as a consequence
of immobilisation13-17. More specifically, bone continuously
modifies and regenerates itself in the presence or
absence of mechanical loading, which subsequently leads
to the accrual (formation), maintenance (homeostasis)
or degradation (resorption) of bone mass18-24. This is
achieved through a sophisticated process involving the
careful cellular regulation and coordination of osteoblasts
(bone matrix deposit) and osteoclasts (bone matrix
resorption) in order to remove damaged or extraneous
bone material and subsequently replace it with new robust
material19-21,25-30. As bone remodelling is a continuous
process, even a slight perturbation or imbalance in
either of these regulatory cells can lead to osteopenia or
osteoporosis; such is the importance of bone health to load
tolerance capabilities29-35. In particular, the mechanical
integrity and performance of bone under various loading
conditions is directly affected by its mechanical properties
and geometric characteristics1,7,12,13,18,36 which are both
347
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indicators of bone health and underpin bone strength.
The ability of bone to withstand forces and moments
(mechanical loads) differs substantially across the loading
spectrum under various loading conditions, specific to the
mode, magnitude, direction, rate and frequency of load
applied3,12,16,17,37-39. As bone is anisotropic in nature, it has
different thresholds of load tolerability across different planes
of action2,18,40,41. Indeed, habitual human behaviours routinely
expose bones to various, often unpredictable loading patterns
spanning from cyclical low-grade forces when walking or
running, to sudden high-grade forces when jumping, landing
or changing direction. As a result, compressive, torsional,
transverse and tensile loads in combination and isolation are
routinely applied to bone, exposing the skeleton to stimuli
that can lead to positive bone-specific and site-specific
adaptations16,42-49, or in the absence of suitable conditioning,
recovery and nutrition, an increased likelihood of injury50-57.
Despite the complex and multidimensional relationship
between various loading schemes and bone mechanical
properties (beyond the scope of this review, and published
earlier12), bone strength and stiffness are greatest
in the direction by which loads are most commonly
expressed13,44,49,58. The prevaling bone structure reflects an
appropriate adaptation to mechanical loading highlighting a
specificity of adaptation (site-specific) as force transmission
regulates osteogenic (anabolic) bone formation outcomes
concomitantly with other stochastic (spatially non-specific)
adaptations2,16,20,21,59. In particular, the regulation and coordination of bone to physically adapt to loading demands
is initiated and managed at the cellular level by osteocytes
through mechanotransduction59-62. Proportionate to
mechanical stimulation, osteocytes biochemically promote
osteogenesis by coordinating osteoblast and osteoclast
activity so that overall bone morphology and bone shape
positively adapts in favour of greater bone strength63-65.
Within this process, older osteoblasts make way for
new osteoblasts by transforming into osteocytes which
become embedded into the bone-matrix. As osteocytes
form 95% of bone-matrix composition, this increase in
osteocyte concentration leads to an increase in bone mass
while maintaining regulatory osteoblast-to-osteoclast
homeostasis7,19-21,66,67.
As reviewed below, bone loss and bone accrual are not
necessarily co-located and occur in a targeted or sitespecific manner around bone circumference and along
its length, additional to observable coadaptive bone
morphological traits. A thorough understanding of these
cellular and physiologic processes and their contribution
to determining and maintaining bone strength will facilitate
clinical diagnostics, designing appropriate interventions,
and evaluating clinical musculoskeletal outcomes of
pharmacological and non-pharmacological interventions68.
Accordingly, this review aims to provide a comprehensive
update of current scientific literature and our understanding
of these processes for clinicians and researchers, in
companionship with the mechanical basis of bone strength12
published earlier.
http://www.ismni.org

Bone strength
Bone strength explicitly refers to the ability of bone to
withstand force prior to catastrophic failure1,24,69-72, and
is inextricably linked with fatigue resistance to repetitive
loads73-78. Given the complex and multidimensional nature of
bone, its strength is ultimately determined by the interaction
and adjustment of its material and structural properties
evident at macroscopic, microscopic and nanoscopic
levels1,70,72,79-82. At the material level, the collagenous
extracellular matrix of bone provides resistance to tension,
whereas the mineral inorganic phase of bone provides
resistance to compression. Indeed, variations in collagen
(such as osteogenesis imperfecta) or mineralisation (such
as anti-resorptive drugs) can weaken or strengthen bone.
Microscopically, the trabeculae in trabecular meshwork have
implications on bone stuctural strength, and macroscopically,
varying the shape of the bone will increase or decrease the
amount of bending and torsion a bone can withstand given a
particular amount of total mineral mass.
The adaptability, modulation and regulation of bone
to mechanical and non-mechanical stimuli provides
practitioners with the ability to directly influence and
target bone strength through numerous interdependent
mechanisms. Specifically, deterministic site-specific bone
strength adaptations are driven by habitual mechanical
loading, whereas general and non-specific bone
strength adaptations are predominantly driven through
endocrinological variations, responsive to physical,
pharmacological and nutritional interventions1,32,33,83-86.
As all forms of bone adaptation collaboratively determine
structural integrity and mechanical competency, it is
desirable to optimise and preserve bone strength during
growth, development, maturity and advanced age through
multi-disciplinary and holistic approaches which importantly
address all bone strength determinants. The biological basis
of bone strength is determined by its structure and function
through its anatomy and physiology.

Bone anatomy
Skeletal function
Our skeletons are responsible for several important
mechanical
and
non-mechanical
functions22,36,87.
Mechanically, they provide a structural framework and stable
foundation for human movement and locomotion to occur,
generating mechanical rigidity and kinematic connectivity
within the body22,36,88-90. It specifically achieves this by
providing skeletal muscle with attachment sites to use as
leverage points and platforms with which to act, contract and
produce force, and serves to protect the brain, spinal cord and
internal organs2,18,26,36,91,92. Non-mechanically, bone provides
a reservoir for mineral deposition and blood regulation of
calcium and phosphorous, supports haematopoiesis, defends
against acidosis, and absorbs or captures potentially toxic
minerals22,26,36,91,93. In order to fulfil these many functions
348
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simultaneously, bone has unique structural, morphological
and mechanical properties that are highly dynamic,
metabolically active and physiologically adaptive to the
environment in which they’re exposed21,23,88,94. Bone is also
highly vascular, facilitating the perfusion of oxygenated blood
to enable the removal of metabolites and provision of nutrient
availability required by bone to constantly model (form new
bone) and remodel (recycle damaged bone) in response
to routinely imposed mechanical demands, subsequently
altering its configuration and material properties to
preserve or increase strength in order to meet its functional
requirements18,19,24,79,89.
In its adult form, the human skeleton consists of
approximately 200 distinguishable bones, with 74 located
in the axial skeleton, and 126 located in the appendicular
skeleton22,95. Long bones, however, are the most commonly
loaded structures and therefore strongest load-bearing
bones in the body, predominantly in the appendicular
skeleton. They comprise of a hollow cylindrical shaft known as
the diaphysis, a cone-shaped proximal and distal metaphysis,
and rounded proximal and distal epiphysis22,96-98, each portion
has different architectural features which are organised and
configured to withstand and manage different physical loads
during regular activities of daily living79,80,88,99.
Macroscopic architecture
Bone is a structurally complex and sophisticated
biomaterial1,2,4,33. It must be rigid and stiff to withstand forces
and accommodate loading, yet be flexible and elastic to deform
and absorb energy24,80,100,101. It must shorten and widen under
compression, yet lengthen and narrow under tension, whilst
also withstanding torsional and shear forces in isolation and
in combination without experiencing catastrophic failure24,79.
In order to manage these contradictory and paradoxical
requirements, the skeleton contains two macroscopic
osseous tissues (trabecular and cortical bone) which are
architecturally and functionally different33,81,102-105. In its
entirety, skeletal mass consists of approximately 20%
trabecular tissue and 80% cortical tissue, which co-exists
at various proportions in all bones through-out the body in
accordance with the functional and regional demands of each
individual bone18,22,79,80,105,106. The structural intricacies and
interactions between these two osseous tissues, enable long
bones to be remarkably light yet durable and strong in order
to facilitate locomotion24,79,82,107,108.

red bone marrow88,102,111-114. The three-dimensional latticelike structure of trabecular bone is primarily organised
in the direction from which the greatest stresses are
most commonly experienced, a design best suited for the
mechanical loading of bone7,89,101,109,114-116. The spongy and
porous architecture of trabecular bone enables it to store
large amounts of energy prior to yielding18,23,105,117,118, thus
allowing it to routinely tolerate cyclical low-grade forces.
Cortical bone
Cortical bone, also known as compact bone, forms the thin
superficial layer of all bones, though is most prominently
found in the thick central cortex (diaphysis) of long bones
through-out the appendicular skeleton2,22,95,119. Cortical
bone encapsulates trabecular bone, however the relative
co-existence and composition of each tissue varies between
bones through-out the skeleton1,18,99,102. In long bones, cortical
tissue is arranged in a cylindrical fashion with concentric
layers across two primary surfaces: the periosteum (a
dense fibrous membrane forming the outside layer) and
endosteum (a thin membrane forming the inner layer) of
the diaphyseal shaft79,95,97,111,119-122. Both surfaces contain
important cells (osteoclasts, osteoblasts and osteocytes)
responsible for modelling and remodelling processes
essential to bone adaptation and osteogenesis17,24,25,97,123.
The endosteum additionally lines the central cavity with
yellow marrow88,95,111,112,122. Structurally, cortical bone is
highly organised, densely packed, rigid, and texturally
smooth18,23,111,120, with mineralized lamellar bone and collagen
fibre matrix most prominently arranged in the direction of
routine mechanical stress69,101,119,120,124,125. This provides
cortical bone with an increased capability to tolerate sudden,
high impact forces i.e. a sample of cortical bone is ~25%
stronger than a sample of trabecular bone1,18,23, 119,126.
Microscopic architecture
Bone also has microscopic and sub-microscopic
levels which, together with the macroscopic level, form a
multidimensional architectural biomaterial with a deliberate
mass (size, geometry and density) aimed at achieving
optimal structural strength1,33,70,73,80. Microscopically, bone
presents in the form of woven and lamellar bone at the
tissue level81,98,127-129, and consists of organic and inorganic
components at the material level26,33,59,130-132.
Tissue level

Trabecular bone
Trabecular bone, also known as cancellous bone, is
encapsulated beneath cortical bone. It is most prominently
found in weight-bearing skeletal structures, specifically
the proximal and distal ends of long-bones (epiphyseal
and metaphyseal regions), the carpals and tarsals of the
extremities, and vertebrae22,79,81,109,110. Texturally, trabecular
tissue presents as a meshwork of bone (trabeculae) with
many interconnecting spaces through-out which contain
http://www.ismni.org

Bone presents in the form of immature (woven) and mature
(lamellar) tissue at different stages of the modelling and remodelling processes at the microscopic level22,100,127,129,133-135.
Woven tissue is an immature form of bone characterised by
a random and spontaneous collagen arrangement, a large
volume of cells, and relatively low tissue density100,104. It is
formed rapidly, producing a highly unorganised and porous
structure22,127,128. Woven bone features primarily throughout development, exclusively forming the entire skeleton at
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birth prior to a gradual transformation into mature lamellar
bone during growth and physical maturation22,98,100,136. At any
other time, woven bone formation occurs only following an
injury or extreme structural overload which is thought to be
a rapid, protective and restorative response to significantly
damaged or weakened hard tissue structures2,127,137-139. It is
therefore considered a premature and provisional material.
Lamellar tissue, however, is a mature form of bone, which
eventually replaces woven tissue in the form of trabecular or
cortical bone formations. Lamellar tissue is characterised by
a precise and deliberate parallel and concentric arrangement
of lamellae sheets produced slowly due to a low turnover
rate2,81,98,134. Lamellae sheets are formed in alternating
directions that vary in rotational position and thickness in
order to optimally withstand mechanical loads, in particular
torsional stress1,81,95,128,134. Lamellar bone is therefore denser
and stronger than woven bone22,100,101,140.
Material level
Bone is a specialised, bi-phasic connective tissue consisting
of extracellular organic material coupled with a uniquely high
content of mineralised inorganic material1,18,33,124,130,141. The
organic portion provides bone with one-third of its mass
and two-thirds of its volume; whereas the inorganic portion
provides bone with the remaining two-thirds of its mass
and one-third of its volume59,70,132. The extracellular organic
component is mostly collagenous, conferring flexibility and
resilience to bone by solidifying in tension as a protection
against stretching, twisting and torsion142-146. Conversely,
the mineralised inorganic component is primarily calcium
and phosphate in the form of an insoluble salt known as
hydroxyapatite130,147-152, giving bone its hardness and rigidity,
particularly in compression153-155. As a result, the overall
structural strength of bone relies upon the joint contribution
and inter-play of these organic and inorganic material
properties1,2,24,148,153, such that variations of inorganic
mineral density will potentially adjust stiffness and flexibility
arrangements in bone24,130,156, the optimal balance of which
remains largely unknown. That is, highly mineralised bone
can become brittle (e.g. atypical femoral fractures), whereas
less mineralised bone will be tougher yet less stiff (e.g.
greenstick fracture). Fortunately, this can be somewhat
examined as elements held within the mineralised (inorganic)
portion of bone provide considerable resistance to X-ray
beams, forming the theoretical basis underpinning the use of
bone densitometry devices.

Bone physiology
Historically, bone has been regarded as the domain
of anatomical study. However mechanically receptive,
biologically adaptive and metabolically active features of
bone have since solidified it as a biomaterial well-suited for
physiological and biomechanical investigation2,12,69,89,157.
In particular, the skeleton is able to construct (model) and
reconstruct (remodel) itself through cellular processes in
http://www.ismni.org

response to developmental and mechanical loading demands
through tightly controlled cellular activities20,21,24,25,91,93,158.
Cellular mechanisms
Bone is generated, regulated and maintained by an
interaction of four key cells: osteoblasts, osteoclasts,
osteocytes and extra-cellular lining cells13,19,26-28,159.
Osteoblasts are anabolic in nature, producing new bone
material by synthesizing and calcifying newly generated
collagen2,21,23,141. Osteoblasts are uniquely adaptable and
compatible, transforming into bone lining cells (surrounding
the extra-cellular matrix) and osteocytes (embedded within
the bone matrix) during the osteogenic process25,160-162.
Conversely, osteoclasts are a catabolic cell which degrades,
dissolves and resorbs bone material, often as a response
to material damage or disuse21,29,123,163. Osteoclasts have
a limited lifespan, undergoing apoptosis (programmed cell
death) within 2 to 4 weeks of osteoclastogenesis25,123,164.
Osteoblasts and osteoclasts work independently during bone
creation and formation (modelling), and co-operatively via a
basic multi-cellular unit (BMU) during bone maintenance and
homeostasis (remodelling).
Osteocytes are central to bone development and renewal
as the most abundant residential cell in bone, accounting for
approximately 90% to 95% of all bone cells66,141,162,165,166.
Specifically, osteocytes are descendants of osteoblasts
produced during osteogenesis, which subsequently become
entombed within the mineralised collagen matrix25,27,66,109,162.
Osteocytes form a well-connected network of sensory
channels to detect environmental alterations and
communicate reactionary processes to osteoblasts, bone
lining cells and fellow osteocytes13,136,165,167,168. This network
is explicitly formed by dendritic connections (~60 to 80
per osteocyte) which proliferate through canaliculated
passages to provide a functional and mechanosensitive
platform integral to the detection of mechanical load and
associated microdamage13,66,158,165,167. This mechanically
sensitive function, known as mechanotransduction, enables
bone to physiologically detect and convert mechanical
energy into proportionate biochemical signals in order
to promote growth and repair processes59,60,65,158,168. The
process of mechanotransduction, including how bones sense
mechanical changes, are described further under the Bone
Adaptation section of this review.
Hormonal mechanisms
Bone growth, development and preservation is largely
reliant upon hormonal regulation, globally controlling skeletal
homeostasis somewhat independently of mechanical loads
through-out the lifespan in order to facilitate non-mechanical
functions of bone33,169-173. Specifically, the endocrine system
serves to maintain bone mineral deposition and homeostatic
cellular balance through continual, non-mechanically induced
generation and regeneration of bone during biological growth
and maturation24,174-177. While the endocrine system does
350
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Table 1. Endocrine regulation of bone metabolism.
Hormones
Growth Regulators
hGH
IGF-1
Glucocorticoids
Ghrelin
Leptin

General Description
Peptide hormone secreted from the anterior pituitary; influences muscle, liver,
kidney and bone; promotes longitudinal growth of bone.
Polypeptide with an essential role in growth and development; primarily
circulated by liver; also paracrine delivered by non-hepatic tissues.
Produced by adrenal glands, inhibits synthesis of IGF-1, supresses BMP-2 and
calcium absorption.
Gut-derived peptide hormone; secretagogue of growth hormone; modulates
energy homeostasis.
Adipocyte peptide hormone; proportional to fat stores; modulates energy
homeostasis.

Thyroxin (T3 and T4)

Tyrosine-based hormones produced by thyroid gland; regulates energy
metabolism through thyroid stimulation hormone (TSH) activity.

ACTH

Peptide hormone secreted from the anterior pituitary; stimulates cortisol
production; dose- dependent proliferation of osteoblast activity.

Oxytocin

Peptide hormone secreted from the posterior pituitary; modulated by estrogen;
autocrine- paracrine osteoblast regulator of formation.

Bone Metabolism
Stimulates Formation
Stimulates Formation
Inhibits Formation
Stimulates Resorption
Stimulates Formation
Inhibits Resorption
Inhibits Formation
Stimulates Resorption
Stimulates Formation
Stimulates Resorption
Net Effect: Homeostatic
Stimulates Formation
Stimulates Resorption
Net Effect: Homeostatic
Stimulates Formation
Stimulates Resorption
Net Effect: Homeostatic

Gonadal Regulators
Androgens
Estrogen

Sex steroid secreted from testes (men) and adrenals (men and women); also
converts to estrogen; acts in presence of hGH.
Synthesised from androgens in ovaries (women) and extra-glandular tissue
(men and women); dominant role in bone metabolism.

Stimulates Formation
Permits Formation
Inhibits Resorption

Calcitropic Regulators
PTH
Calcitonin
Vitamin D3

Polypeptide secreted by parathyroid gland, tightly controls calcium and
phosphate; acts to maintain bone mineral homeostasis.
Secreted by thyroid gland when plasma calcium is elevated; lowers plasma
calcium; deposits into bone; relatively weak in comparison to PTH.
Activated in the liver and kidney; essential for intestinal absorption of calcium
and phosphate; deficiency results in bone demineralisation.

not explicitly strive to optimise bone strength, endocrine
status can have a profound, indirect and negative impact
on structural integrity and mechanical competency when
irregular hormonal environments arise172,173,178-183. Endocrine
activity therefore forms a central component of a complex
biological system that mediates calcium-phosphate balance,
energy metabolism and bone mineralisation in response to
dynamic and volatile physiological requirements179,184-190.
In this regard, endocrine function majorly influences bone
health and metabolism, ascending into domination through
adulthood and advanced ageing169,175,178,182,183,191,192.
Endocrinological regulation of bone metabolism is highly
influenced and tightly controlled by sub-categories of growth,
gonadal and calcitropic hormones (Table 1), with varying
levels of contribution and relative dominance through-out
life170,174,175,178,187-206. Specifically, growth hormones exert
formative effects; gonadal hormones exert formative and antihttp://www.ismni.org

Stimulates Formation
Stimulates Resorption
Net Effect: Formation
Stimulates Formation
Inhibits Resorption
Permits Formation
Stimulates Resorption

resorptive effects; and calcitropic hormones exert homeostatic
effects; co-operatively acting to promote bone mass accrual
during growth and maturation171,178,179,183-186,189,192,207-213.
However, hormonal activity begins to decline following
the establishment of peak bone mass, as bone formation
and resorption shifts from net formation during ontogeny,
to equilibrium during early-to-middle adulthood, and net
resorption during advanced and older age24,34,71,173,214.
This imbalance in bone metabolism is primarily driven by
altered endocrine-paracrine activity, and confounded by
multi-dimensional, synergistic and antagonistic hormonal
interactions necessary to achieve and maintain metabolic
homeostasis21,23,123,191,215. As a result, hormonal imbalances
and environmental irregularities underpinning deficient
endocrine function form the nutritional and pharmacological
basis of bone preservation strategies34,214,216-218, utilising
natural and artificial suppression and stimulation of bone
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Figure 1. Mechanotransduction (adapted from 14,15): illustrating the hierarchical structure of bone and the organizational structure
of osteocytes within (left); and the mechanically induced fluid flow from hydrostatic pressure and osteoprogenitors through which
biochemical signals proliferate (right).

resorption and formation to prevent and manage pathogenic
conditions through-out the life-span.

Bone adaptation
Mechanotransduction
Bone modelling and remodelling paradigms pioneered
by Julius Wolff, improved by Wilhelm Roux (Wolff’s Law),
and expanded upon by Harold Frost (Mechanostat Theory),
remain the central focus of emerging and contemporary
research11,89,219-233. Their meritorious work collectively
describes the ability of bone to alter its mass and structure
in response to routine mechanical loads15,69,92,106,234-238.
However, scientific understanding of this mechanobiological
relationship remains elusive and poorly understood. The
conceptual basis of mechanical events stimulating and
mediating bone formation, adaptation, maintenance and
repair is widely accepted2,15,61,141,239. However, the cellular
mechanisms and structural framework which underpins this
observed phenomenon is not yet fully understood and forms
the basis of current-day research15,59,62,67,240,241.
In principle, mechanotransduction (Figure 1) refers to
the conversion of biophysical forces (mechanical load) into
http://www.ismni.org

cellular responses which drive morphological change at the
tissue level, a functional adaptation of bone which purposely
improves structural integrity and strength13,63-65,158,242,243.
This biologic detection of mechanical force and their
conferred cellular responses primarily involve four key
activities: 1) mechanical coupling, 2) biochemical coupling,
3) signal transmission, and 4) effector response60,63,98,133,244.
Specifically, forces which lead to bone deformation create
interstitial fluid movement within canaliculi, stimulating
biochemical activity via mechanosensory cells64,245-251.
Piezoelectric signals are then transmitted through
comprehensive lacuno-canalicular networks of osteocytes,
lining cells and osteoblasts to determine the format and
magnitude of cellular response relative to the perceived
dose of mechanical load59,65,98,113,141,252-255. This fundamental
dose-response relationship between mechanical load and
structural bone adaptation provides the foundation of bone
modelling and re-modelling theory63-65,158,240,243,256.
Modelling
Modelling is a dynamic and constructive process which
adjusts the size, shape and strength of bone in order to
352
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Figure 2. Bone mineral density accrual, maintenance and loss through-out the life-span as indication of bone mass alterations; with
approximately 50–60% of total adult bone mass gained during adolescent years preceding peak bone mass and skeletal maturity at ~30
years of age. Bone mass deteriorates gradually following peak bone mass into older age to within normal (green), osteopaenic (yellow)
or osteoporotic (red) bone density ranges.

achieve its structural potential during ontogeny, specifically
in response to physiological and mechanical influences
through-out physical maturation22,79,111,122,257-259. It comprises
of a complex and multifarious array of cellular and material
activity which interact to position and configure cells and
matrices during growth and development7,69,239. At the cellular
level, osteoblasts work independently from osteoclasts to
create an environment where matrix deposition exceeds
matrix resorption11,15,22,111,260,261. At the tissue level, this is
expressed through periosteal apposition and simultaneous
yet slower endocortical resorption22,73,82,97,107,111,122,261,262,
leading to the formation of new bone material and partial
preservation of old bone material to deliver a net increase in
bone mass15,24,79,243,263,264.
Longitudinal and radial growth are developmental
features of depositional modelling during ontogeny. In
particular, collagen is synthesised and deposited onto the
extracellular matrix in order to elongate, thicken and widen
the periosteum, while endocortical resorption expands the
marrow cavity to concurrently increase the diameter of the
endosteum together with the periosteum22,69,79,82,97,107,122,265.
These morphological alterations structurally enhance bone
strength through two key mechanisms: 1) increasing the
bony (i.e. excluding any cavities) cross-sectional area, and
2) by placing the material farther from the centre of the bone,
which increases the polar moment of inertia1,22,69,73,82,258.
Increasing the amount of bone material in a given crosssection improves bone strength in compression and tension,
whereas distributing bone material farther from the centre
of the bone improves strength in bending and torsion. For
further details on bone mechanics, refer to our companion
review12. Ultimately, these morphological alterations keep
http://www.ismni.org

stresses and strains of applied mechanical loads within a
desired range by distributing compressive forces over a
larger area, while also resisting bending and twisting forces
at the mid-shaft69,72,73,107,266-268.
Bone formation is presently thought to be limited to
the first three-decades of human life, achieving maturity
at this time to establish peak bone mass269-271. The
potential of bone to develop during growth is influenced
by a range of non-modifiable (gender, ethnicity, genetics)
and modifiable (nutrition, hormones, lifestyle, physical
activity) factors which ultimately determine skeletal
development73,82,97,257,262,267,272-277. However, the accrual of
bone is not a linear process, with bone developing most rapidly
in adolescent years, acquiring ~50 to 60% of total adult
bone mass within this short and critical period of time216,278282
. Given the heightened sensitivity and responsiveness
of bone during its premature stage of life, a considerable
opportunity (window of adaptation) is provided to improve
skeletal robustness and resilience through maximising bone
mass during early-stage development83,267,283-290. Despite
this apparent ceiling of bone mass augmentation (Figure
2), bone strength is able to increase through other spatially
relevant mechanisms in maturity using a regulatory process
known as re-modelling33,73,79,91,269,291,292.
Remodelling
Remodelling is an on-going, homeostatic and
restorative process which replaces old and damaged
bone with new and healthy material (Figure 3) to
maintain and improve structural integrity and mechanical
competency19-21,23,26,29,82,107,159,293. The regulatory nature of
353
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Figure 3. A graphical representation of the remodelling cycle (adapted from 24). Bone resorption (left) is stimulated by a micro-crack which
severs canaliculi channels between osteocytes leading to osteocytic apoptosis. Lining cells and osteocytes release signals attracting
cells from blood and marrow reservoirs into the damaged area leading to osteoclastogenesis. Bone formation (right) commences with
successive streams of osteoblastic activity depositing new lamellar bone. Osteoblasts then transform into new lining cells (extra-cellular
layer) or osteocytes (embedded in osteoid and bone matrix).

Table 2. Adult bone remodelling (adapted from 96,109110,123).
• Lifespan of BMU: ~6-9 months
• Duration of remodelling: ~4-6 months
• Speed of remodelling: ~25 µm/day
• Bone volume replaced by a single BMU: ~0.025 mm3
• Lifespan of osteoclasts: ~2 weeks
• Lifespan of osteoblasts (active): ~3 months
• Interval between successive remodelling events at the same location: ~2-5 years.
• Rate of turnover of whole skeleton: ~10% per year a
a
10% per year approximation assumes 4% turnover per year of cortical bone (75% of the skeleton), and 28% turnover per year of
trabecular bone (25% of the skeleton): Calculated as [0.75 x 4] + [0.25 x 28] = 10%; BMU = basic multicellular unit.

re-modelling relies upon integrated sensory signals in order
to provide a feedback-controlled modulation of skeletal
structure; a mechanism designed to sustain current and
future functional requirements20-24,79,80,91,111. This complex
and multidimensional process is essential to ensure bone
structure remains balanced between excessive bone mass
and excessive bone fragility (a continuum of robustness to
slenderness) in order to optimise bone strength without
sacrificing mobility; one of many paradoxical expressions of
bone adaptation17,25,29,82,107,123.
Remodelling occurs through stochastic and deterministic
mechanisms19,20,59,80,91,294.
Stochastic
remodelling
describes randomly delivered and spatially non-specific
forms of regeneration via the endocrine system, whereas
deterministic remodelling forms the morphological and
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mechanosensitive basis of bone strength adaptation
through-out
the
lifespan15,17,123,293,295.
Specifically,
deterministic remodelling represents a precisely assigned,
targeted and site-specific form of remediation to repair
damaged bone or initiated as a consequence of mechanical
behaviour2,19,237,292,293,296,297. In particular, bone acutely
and accumulatively incurs microdamage in response to
mechanical loading (gravitational and muscular forces),
requiring coordinated cellular-level and tissue-level activity
in order to manage and prevent structural failure and bone
fracture21,59,79,80,297. As a result, bone is resorbed in regionally
and temporally distinct locations, detected and driven at the
cellular level by osteocytes through mechanotransduction in
order to target, repair and replace damaged material at the
tissue-level19,20,24,29,79,293,296.
354

N.H. Hart et al.: Biological basis of bone strength

Unlike modelling, remodelling requires a coordinated, tightly
coupled and sequentially activated cellular response between
osteoclasts and osteoblasts in order to resorb damaged bone
and deposit healthy bone without sacrificing mechanical
competency19,29,33,111,159,242.Thisresponseiseffectuatedbybasic
multicellular units (BMU’s), temporary structures composed
of grouped osteoclasts and osteoblasts in the presence
of blood supply and connective tissue11,21,26,82,110,219,298,299.
Biologically, these multicellular units are similar between
cortical and trabecular bone, following a standard activationresorption-formation sequence via osteocyte-osteoclastosteoblast integration23,25,123,242,294,299,300. However, owing to
their differences in organisation, morphology and vascular
supply, cortical bone remodels using a tunnel-like resorptive
cavity (2000 µm long; 200 µm wide), with a low surfaceto-volume ratio and slow turnover rate; whereas trabecular
bone remodels using a superficial trench-like resorptive
cavity (60 µm deep), with a high surface-to-volume ratio and
faster turnover rate7,17,20,23,242. As a proportion of total skeletal
mass, approximately 3 to 5% of cortical bone and 25 to
28% of trabecular bone is remodeled each year, completely
regenerating the adult skeleton approximately every 10
years23,27,110,123.
Degradation
Degradation is a gradual deconstructive process whereby
bone material and structure begin to decline and decay
through catabolic cellular activity such that resorption
exceeds deposition overtime, subsequently compromising
the mechanical competency and ultimate strength of
bone17,296,301-304. This occurs through non-mechanical and
mechanical mechanisms in isolation and combination.
Non-mechanical degradation represents bone loss during
advanced biological ageing and associated pathological
conditions such as osteopenia, osteoporosis and other
disease-states26,33,34,79,84,305-308;
whereas
mechanical
degradation refers to environments of disuse (immobilisation
and microgravity) or overuse (repetitive loading) which
are preventable and reversible17,309-315. As the cellular
governance of bone generation, regeneration and repair is
mainly responsive to mechanical load11,17,24,157,277,296,304,306,316
, the absence or overload stimulus can lead to net-resorptive
activity and subsequent bone degradation26,303,307,312, 317-319.
Removal of mechanical loads through microgravity
(space travel), disuse (immobilisation) or spinal cord
injury (partial or complete paralysis) results in rapid loss
of bone mass303,309,312,315,320-332. Specifically, bone density
decreases by ~2% each month through microgravity, partial
paralysis or immobilisation without injury, and ~7% each
month following complete paralysis or immobilisation with
associated musculoskeletal injury17,26,303,319,321,322,333-338.
However, actual strength loss is likely greater, as
concurrent reductions in cross-sectional area and mineral
content are concealed by bone density measures, yet have
dramatic consequences on bone strength1,36,70,73,80,103,316,339.
Nevertheless, bone loss is incremental and progressive
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with time and occurs more rapidly in trabecular bone
than cortical bone, owing to their different rates of
responsiveness to muscular and gravitational osteogenic
stimuli17,26,103,115,307,308. In reversible situations, the timecourse and magnitude of recovery is markedly slower and
more gradual than loss17,309,315,319,326,327,340,341.
Bone loss is also uniquely layer specific within the
skeleton, eloquently demonstrated in ageing and spinal cord
injury cohorts303,342. Specifically, through aging or following
spinal cord injury, bone cross-sectional area observably
loses material from the endosteal border and intra-cortically,
with no clear evidence at the periosteal level102,343,344. For
example, individuals with traumatic paralyisis prior to
growth cessation develop smaller periosteal circumferences
relative to non-paralysed referents, however individuals
paralysed after growth cessation have similar periosteal
circumferences to non-paralysed referents303,342,345-347.
Conversely, bone accretion can occur at the endosteal and
periosteal surfaces348-350, however whether or not agerelated endosteal and intracortical bone resorption can
be reduced or prevented with skeletal loading is currently
unclear351,352. In contrast to deterministic mechanical loading
effects, antiresorptive and proformative drugs exert their
effects systemtically (stochastically) through-out bone
material353-355. Taken together, while cellular proceses are
tighly coupled, whole organ bone resorption and accretion
may be situated at different locations within and along the
bone, and that particular surfaces may be preferentially
affected. This complex inter-play of bone loss and bone
accretion across bone cross-sectional areas and along
bone lengths requires dutiful consideration when designing
and evaluating mechanical, dietary or pharmacological
interventions.
Excessive mechanical loads supplied through repetitive
and cyclical activity may also yield net-resorptive and
degradative effects on bone38,52,74,75,356. In the absence of
appropriate recovery, bone fatigue leads to the accumulation
of microdamage and coalescence of microcracks,
subsequently increasing the total magnitude and rate
of remodelling activity at any given time51,75,296,357-359.
Given that bone reparation requires damaged tissue to
be removed (~1 month) and then replaced (~3 months) at
various bone sites simultaneously; excessive magnitudes
and rates of remodelling have considerable microstructural
consequences, progressively weakening bone through
loss of stiffness and strength until eventual failure in the
form of stress reactions, stress fractures, or heightened
susceptibility to traumatic fracture38,51,52,74,91,356,358. In this
regard, weakened bone acquires damage at lower relative
strain magnitudes; thus fatigued bone creates a progressive
and positive feed-back loop between mechanical load and
damage accumulation57,76,157,301,304,317,358-360. Increasing bone
strength reduces fatigability to customary loads, providing
greater protection against exercise-induced degeneration,
however, more importantly, rest and recovery periods are
imperative to ensure structural integrity and mechanical
competency remain1,17,70,157,306,361.
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Figure 4. Material and structural determinants of bone strength or fragility (left) with associated technologies required to examine bone
properties (right); along the macroscopic, microscopic and nanoscopic continuum [top to bottom], (adapted from 1).

Measuring bone strength
Bone material, structure and strength must be
quantifiable in order to examine, diagnose, monitor and
manage skeletal health and bone quality cross-sectionally
and longitudinally as a mechanism to establish interventional
efficacy of programs designed to enhance or preserve bone
strength1,24,36,362,363. However the accessibility of bone invivo remains a constant barrier to scientists. While cadavers
are often used to investigate historical events and lasting
transactions in bone76,78,364-366, understanding the volatile
and evolving adaptations of living and responsive hard-tissue
remains elusive24,367,368. Modern-day advancements have
attempted to overcome such limitations by developing a
multitude of technologies (Figure 4) aimed at non-invasively
measuring bone density, structure and strength of various
depths, scales and resolutions1,369-372. Owing to their relative
cost, availability and levels of radiation exposure, DXA and
pQCT are commonly used bone densitometry devices in
clinical and research environments372-377, often supported
by the collection of biochemical markers through serological
and urianalytical samples as surrogate measures of bone
metabolism87,378,379.
Dual-energy X-ray absorptiometry
Dual-energy X-ray Absorptiometry (DXA) is a lowresolution, uniplanar, two-dimensional bone densitometry
imaging device which measures full-body and segmental
projections of mass quantities and densities in-vivo using lowlevel radiation through x-ray technology374,380. Specifically,
DXA emits two distinct photon energies (140 KeV/70 KeV)
via collimated pencil, fan or narrow beams which pass through
http://www.ismni.org

the individual; the attenuation coefficients and ratios of
which differentiate hard tissue from soft tissue, and fat mass
from lean mass in an expedient and effective manner380-382.
Importantly, DXA quantifies areal bone mineral density
(aBMD) and its derivatives (bone area and bone mineral
content) in order to examine bone quality383-385, while also
measuring body composition, specifically quantifying soft
tissue (fat mass and lean mass) simultaneous with hard tissue
(bone mass) in order to concurrently measure materials
which co-adapt with each other381,386-388. While DXA produces
valid and reliable, scan-rescan measures of whole-body bone
mass characteristics and body composition components,
numerous standardised nutritional, procedural and analytical
controls are required to ensure longitudinal integrity of
measures when examining interventional efficacy386,389-394.
Bone health and skeletal fragility diagnoses of bone
disorders are clinically defined by the World Health
Organisation using DXA-derived aBMD T-scores from
population-based reference values, highlighting its
established and reputed position as the gold standard in
clinical environments384,395-397. However, clinical examinations
using DXA technology are inherently flawed, as bone
material (architecture) and structure (size and shape) cannot
be measured374,383,398,399. Specifically, DXA’s uniplanar, lowresolution images restrict clinicians to descriptions of whole
bone mass, which only partially explains bone strength
variation24,398,400-402. Inaccurate diagnoses of osteoporosis
therefore prevail, with many fragility fractures prevalent in
categorically low-to-moderate risk individuals, classified
within normal or osteopenic regions72,275,373,397,403, further
confounded by regional disparities and T-score variations
between measurable sites within a given individual. Indeed,
denser bone isn’t always stronger, and low density isn’t
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Table 3. Available biochemical markers used to examine formative, resorptive and rate of bone metabolism through serological and
urianalytical mechanisms87,431.
Biochemical Marker
Bone Alkaline Phosphate
Osteocalcin
Carboxyterminal, Type I Collagen
Aminoterminal, Type I Collagen
Pyridinoline
Deoxypiridoline
Carboxyterminal Crosslink, Procollagen I
Carboxyterminal Crosslink, Type I Collagen
Aminoterminal Cross-link, Type I Collagen
Tartrate-resistant Acid Phosphate
Parathyroid Hormone
Note: Information adapted from 69,431.

Abbreviation
BAP / BALP
OC / BGP
PICP
PINP
PYR
DPD / D-PYR
ITCP
CTx
NTx
TRAP5
PTH

always osteoporotic383,384,403,404, thus no identifiable
total body or site-specific BMD threshold abruptly or
disproportionately increases fracture risk. Instead, BMD is
continuously variable with fracture risk, such that lower BMD
equates to higher fracture risk, however does not explicitly
predict it373,384,401,404. Therefore, more refined and detailed
analyses of bone material and structure are required for more
appropriate and predictive diagnoses, potentially deliverable
with other technologies24,383,385,399,405,406.
peripheral Quantitative Computed Tomography
Quantitative Computed Tomography (QCT, axial; pQCT,
peripheral) is a multi-planar, three-dimensional bone
densitometry imaging device which measures the material
and structural properties of bone at macroscopic depth,
providing clinicians with more accurate descriptions of
bone shape, size and quality399,407,408. Specifically, pQCT
transmits targeted collimated beams at selected sites along
the length of a given long bone, reconstructing rotational and
contiguous two-dimensional samples at each site to deliver
a three-dimensional cross-sectional tomographic image of
bone, muscle and fat409-411. As a result, pQCT devices are
able to provide unobstructed circumferential measures
of hard- and soft- tissue masses, generating volumetric
measures of area, content and density for trabecular bone,
cortical bone, marrow, muscle and fat compartments; bone
strength indices and fracture loads; periosteal and endosteal
size; cortical thickness; and bone mass410-414. Diagnostically,
this enables pQCT to address many limitations previously
experienced through DXA examinations which provide
precise, stable and reliable measures of bone and muscle
components333,376,383,399,407,411,412,415.
Bone quality and skeletal fragility examinations using pQCT
are superior to those provided by DXA373,408,414,416. Importantly,
applications of mechanical assumptions to quantified material
http://www.ismni.org

Sample
Serum
Serum
Serum
Serum
Serum & Urine
Serum & Urine
Serum
Urine
Urine
Serum
Serum

Bone Metabolism
Formation
Formation
Formation
Formation
Resorption
Resorption
Resorption
Resorption
Resorption
Resorption
Turnover Rate

and structural properties across numerous cross-sections
allow indices of bone strength to be established, providing
better predictive accuracy of fracture risk beyond generic
aBMD and vBMD measures383,408,412-415,417,418. Despite the
advantageous diagnostic power afforded to clinicians using
pQCT, complexity arises as normative and comparative data
for general, specific and special populations scarcely exist at
present, owing to its emerging status as an alternate imaging
device in clinical and research environments373,399,419-422.
Supplementing DXA measures with pQCT measures has
been suggested as a potential solution for a detailed insight
of bone strength adaptation and fracture risk with clinically
relevant reference values423. Some forms of pQCT are
limited to macroscopic depth, however the emerging use
of micro-scanners (HR-pQCT) provides higher resolution
images that are capable of detecting critically important
microarchitectural features including trabecular thickness,
connectivity and number; cortical porosity; volume fraction;
and arterial calcification127,369,417,418. HR-pQCT is still gaining
ascendency in clinical and research settings due to its
relative infancy in development, high associated cost, and
limited ability to access an array of peripheral skeletal
sites. HR-pQCT is likely to increase in popularity given
the diagnostic importance and catastrophic consequence
of microarchitectural deterioration in disease-states
and advanced ageing, particularly as its technology and
capabilities evolve80,127,275,403,424.
Biochemical markers
Serological and urianalytical provisions of biochemical
markers provide clinicians with a useful methodology to
examine physiological alterations in bone metabolism,
specifically the prevalence of formative and resorptive activity
within the skeleton425-428. Bone mass accrual, maintenance
and degradation are explicitly determined by counteracting
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metabolic processes (formation and resorption) responsive
to endogenous (hormones, cytokines, growth factors) and
exogenous (mechanical loading) factors318,378,429,430.
Biomarkers become clinically useful to examine bone
turnover rates underpinning bone health or skeletal disease
(Table 3) and importantly quantify acute and chronic
metabolic alterations to experienced stimulus and targeted
interventions87,368,379,425-427,432. While biochemical samples
are easily collected and analysed, do not involve harmful
radiation, and have high sensitivity to change; their diagnostic
capabilities in isolation are limited87,368,433,434. In particular,
biomarker concentrations and behavioural profiles are highly
variable between individuals, and indiscriminately represent
global anabolic or catabolic activity of the entire skeleton,
such that biomarker analyses cannot provide targeted
and localised examinations of formative and resorptive
behaviour368,433,434. However, owing to its sensitivity to
measure dynamic early onset alterations, biochemical
markers can be complementary to other bone quality and
skeletal fragility examinations, performed in conjunction with
static morphological measures provided by radiographic and
densitometric devices87,378,427,435,436.

Conclusion and future research
Bone is impressive in its design, architecture and
maintenance as a living biomaterial with distinct porosities
(trabecular and cortical), tissues (woven and lamellar) and
materials (organic and inorganic) that, together, form a robust
multidimensional structure (macroscopic to nanoscopic)
with a deliberate mass (size, geometry and density) aimed at
achieving optimal mechanical strength to support locomotion
and activities of daily living. Growth, development and
homeostasis is eloquently achieved through tightly coupled
cellular processes (osteoblasts, osteoclasts, osteocytes
and bone lining cells) which underpin bone quality and the
continual generation and regeneration of bone in response
to mechanical loading and damage acquisition through
mechanotransduction.
Although, broadly speaking, bone resorption and
formation are tightly coupled, the balance between these
two processes can tilt to favour one or the other resulting
in net gain or net loss. Key reasons for shifts in otherwise
homeostatic balance can be due to the presence or absence
of mechanical loading, metabolism (for example, withdrawal
of female reproductive hormones through menopause),
or pathology. Moreover during growth and development,
formation and resorption are not necessarily co-localised in
bone (for example, transformative morphological narrowing
of long bone metaphyses to become diaphyseal). In addition
to understanding the net effect, it is important to realise that
the timing and duration of bone resportion and formation
do not necessarily happen concurrently. Rather, bone
resorption takes less time than formation and typically
precedes formation. Additionally, bone formation occurs
across essentially two phases: 1) laying down the collagen
http://www.ismni.org

meshwork, and 2) subsequent mineralisation (explained
further in our companion review paper12). In terms of the
gross bone morpohology, it bears repeating that responses
to mechanical loads are site-sepcific. That is, it is entirely
possible to have strong lower limb skeletal structures
yet weak upper limb skeletal structures as is the case in
endurance runners for example. Moreover, even within a long
bone, at a particular site-specific location along the length of
the bone, it is possible to lay new bone material in particular
directions, while the direction at a right angle remains
unmodified by loads, and similarly, the diaphysis may adapt
while no changes are observed in the epiphysis.
This review highlights the complexity of evolving bone
morphology, specific to bone anatomy and physiology,
underpinning the biological basis of bone strength, and
the many cooperative or competing processes required to
delicately maintain bone health. Taking the above together,
we assert the need for clinicians and researchers to
understand and thus consider the underlying physiology
and technical limiations of assessing bone as paramount
in devising appropriate clinical measurement and active
monitoring strategies to allow timely yet accurate
assessments which capture the properties of interest. For
example, attempting to capture bone formation with x-raybased, bone densometric methods will fail unless sufficient
time for mineralisation is allowed as only the mineral
incorporated into the bone contributes meaningfully
to absorbing the radiation used to assess the bone. To
this end, for clinical or research interventions aiming to
evaluate observed x-ray based, densiometric changes in
such properties, a minimum of 6 to 12 months would be
our recommendation. Similarly, in-vivo and non-invasive
methodologies to assess the quality and properties of
type 1 collagen at given bone sites or skeletal regions is
a potentially necessary yet presently absent assessment,
relying solely on systemic biomarkers (from serum or
urine) or bone biopsy, thus limiting the accessibility and
our understanding of the organic matrix of bone. Owing
to the dynamic nature of bone biology, and its complex
and routine interaction and communication between bone
cells and other bodily organs, a deeper recognition and
understanding of the governance and subservience of
various processes and organs within the human body, such
as muscle-bone interactions (described in our companion
review12), will continue to produce new knowledge and
assist clinicians and researchers in the development new
therapeutic approaches to bone diseases, and management
of bone health across the lifespan.
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